Heart Failure

Heart Failure - 2017 Update

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/244042

Contents of this Issue

Navigation

Page 61 of 61

Disclaimer is Guideline attempts to define principles of practice that should produce high-quality patient care. It is applicable to specialists, primary care, and providers at all levels. is Guideline should not be considered exclusive of other methods of care reasonably directed at obtaining the same results. e ultimate judgment concerning the propriety of any course of conduct must be made by the clinician aer consideration of each individual patient situation. Neither IGC, the medical associations, nor the authors endorse any product or service associated with the distributor of this clinical reference tool. Abbreviations ACCF, American College of Cardiolog y Foundation; ACE, angiotensin- converting enzyme; ACEI, angiotensin-converting enzyme inhibitor; ACS, acute coronary syndrome; ADHERE, Acute Decompensated Heart Failure National Registry; AF, atrial fibrillation; AHA, American Heart Association; AMA-PCPI, American Medical Association– Physician Consortium for Performance Improvement; ARB, angiotensin-receptor blocker; ARNI, angiotensin receptor-neprilysin inhibitor ;BMI, body mass index; BNP, B-type natriuretic peptide; BTT, bridge to transplantation; CABG, coronary artery bypass gra; CAD, coronary artery disease; CHARM, Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity; COPD, chronic obstructive pulmonary disease; COR, Class of Recommendation; CORONA, Controlled Rosuvastatin Multinational Trial in Heart Failure; CR, controlled release; CrCl, creatinine clearance; CRT, cardiac resynchronization therapy; CRT-D, cardiac resynchronization therapy with defibrillator; DCM, dilated cardiomyopathy; ECG, electrocardiogram; EF, ejection fraction; EFFECT, Enhanced Feedback for Effective Cardiac Treatment; ESCAPE, Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness; GDMT, guideline-directed medical therapy; HF, heart failure; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; HRQOL, health-related quality of life; hydral-nitrates, hydralazine and isosorbide dinitrate; ICD, implantable cardioverter-defibrillator; INTERMACS, Interagency Registry for Mechanically Assisted Circulatory Support; I-PRESERVE, Irbesartan in Heart Failure With Preserved Heart Function; LA, le atrial/le atrium; LAD, le anterior descending ; LBBB, le bundle-branch block; LOE, Level of Evidence; LV, le ventricle/le ventricular; LVEF, le ventricular ejection fraction; LVH, le ventricular hypertrophy; LVSD, le ventricular systolic dysfunction; MCS, mechanical circulatory support; MI, myocardial infarction; MRI, magnetic resonance imaging ; N/A, not applicable; NNT, number needed to treat; NQF, National Quality Forum; NT-proBNP, N-terminal pro-B-type natriuretic peptide; NYHA, New York Heart Association; OPTIMIZE-HF, Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure; PCI, percutaneous coronary intervention; PCWP, pulmonary capillary wedge pressure; PUFA, polyunsaturated fatty acid; RA, right atrial/right atrium; RAP, right atrial pressure; RCTs, randomized, controlled trials; RR, relative risk; RV, right ventricle/right ventricular; SCD, sudden cardiac death; SIHD, stable ischemic heart disease; STEMI, ST-elevation myocardial infarction; UA/NSTEMI, unstable angina/non–ST-elevation myocardial infarction; VHD, valvular heart disease; VO 2 , oxygen consumption; XL, extended release. Source Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, Drazner MH, Filippatos GS, Fonarow GC, Givertz MM, Hollenberg SM, Lindenfeld J, Masoudi FA, McBride PE, Peterson PN, Stevenson LW, Westlake C. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiolog y/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017;000:e000–e000. DOI: 10.1161/ CIR.0000000000000509. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJV, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WHW, Tsai EJ, Wilkoff BL. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiolog y Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013 Oct 15;62(16):e147-239. Copublished in Circulation. 2013 Oct 15;128(16):e240-327. 106 Commerce Street, Suite 105 Lake Mary, FL 32746 TEL: 407.878.7606 • FAX: 407.878.7611 Order additional copies at GuidelineCentral.com Copyright © 2017 All rights reserved ACCHEA17062d

Articles in this issue

Links on this page

view archives of Heart Failure - Heart Failure - 2017 Update